Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2012
02/02/2012WO2011109732A3 Reverse thermal gels and uses therefor
02/02/2012WO2011106788A3 Car peptide for homing, diagnosis, & targeted therapy for pulmonary and fibrotic disorders
02/02/2012WO2011106684A3 Compositions and methods for modulating autophagy
02/02/2012WO2011100428A3 Compositions for improving bone mass
02/02/2012WO2011081465A9 Pharmaceutical composition for suppression of vascularization
02/02/2012WO2011079073A3 Herpes simplex virus vaccines
02/02/2012WO2011036443A9 S1 protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders
02/02/2012US20120030838 Novel fungal enzymes
02/02/2012US20120030779 Compositions and methods for detecting, treating, or preventing reductive stress
02/02/2012US20120029168 Method for ameliorating pain by modification of nmda receptors through inhibition of src
02/02/2012US20120029061 Rna sequence-specific mediators of rna interference
02/02/2012US20120029049 Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
02/02/2012US20120028944 Cyclodextrin nanotechnology for ophthalmic drug delivery
02/02/2012US20120028913 Peptides for inhibiting chemokine binding to chemokine receptors
02/02/2012US20120028912 Methods of modulating bromodomains
02/02/2012US20120028911 Mucin Derived Polypeptides
02/02/2012US20120028910 Storage-stable aqueous ophthalmic formulations
02/02/2012US20120028909 FN14/TRAIL Fusion Proteins
02/02/2012US20120028908 Methods of Manufacturing Crystalline Forms of Rapamycin Analogs
02/02/2012US20120028907 Methods for identification of tumor phenotype and treatment
02/02/2012US20120028906 Method for affecting the timing of cervical ripening and for parturition
02/02/2012US20120028905 Isolation, Purification, and Structure Elucidation of the Antiproliferative Compound Coibamide A
02/02/2012US20120028904 Methods, systems, and compositions for calpain inhabition
02/02/2012US20120028903 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor
02/02/2012US20120028902 Peptide availability
02/02/2012US20120028901 Tfpi inhibitors and methods of use
02/02/2012US20120028900 Method of producing factor viii proteins by recombinant methods
02/02/2012US20120028899 Composition and process for synthesizing tense and relaxed state polymerized hemoglobin
02/02/2012US20120028898 Methods for treatment of headaches by administration of oxytocin
02/02/2012US20120028897 Methods and compositions for the treatment of fluid retention disorders
02/02/2012US20120028896 Use of fibroblast growth factor fragments
02/02/2012US20120028895 Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control
02/02/2012US20120028894 Peptides, pharmaceutical compositions comprising same and uses thereof
02/02/2012US20120028893 Adenovirus 36 E4 ORF 1 Gene and Protein and Their Uses
02/02/2012US20120028892 Inhibitors of fructose 1,6-bisphosphatase and methods of use thereof
02/02/2012US20120028891 Methods of promoting or maintaining an anabolic state in a female animal
02/02/2012US20120028890 Acid containing lipid formulations
02/02/2012US20120028889 Integrase cofactor
02/02/2012US20120028888 Apj receptor compounds
02/02/2012US20120028887 Lipopeptide inhibitors of hiv-1
02/02/2012US20120028883 Complex and production process
02/02/2012US20120028882 Method for removing endotoxin from proteins
02/02/2012US20120028881 Methods and reagents for diagnosing atheroma
02/02/2012US20120028880 Vegfr-1/nrp-1 targeting peptides
02/02/2012US20120028879 Highly sensitive detection method for highly virulent oral cavity bacteria
02/02/2012US20120028878 Membrane Evaporation for Generating Highly Concentrated Protein Therapeutics
02/02/2012US20120028877 Self-Buffering Protein Formulations
02/02/2012US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof
02/02/2012US20120028262 Genes and polypeptides relating to human pancreatic cancers
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027872 Apparatus for sealing a puncture by causing a reduction in the circumference of the puncture
02/02/2012US20120027858 Methods and Compositions for Managing Cancer Cell Growth
02/02/2012US20120027850 Compositions and Methods for Treatment of Aortic Fibrosis
02/02/2012US20120027848 Enzyme Delivery Systems and Methods of Preparation and Use
02/02/2012US20120027846 Anti-viral azide containing compounds
02/02/2012US20120027845 Adenovirus AD36 E4 ORF1 Protein For Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
02/02/2012US20120027843 Hb-egf bound protein complex
02/02/2012US20120027842 Topical formulations of flap inhibitors for administration to an eye
02/02/2012US20120027835 Surgical prosthesis having biodegradable and nonbiodegradable regions
02/02/2012US20120027832 Use of edds and calcium ions as enhancers of molluscicidal activity
02/02/2012US20120027815 Use of plasma membrane calcium atpase (pmca) inhibitors to inhibit sperm mobility
02/02/2012US20120027814 Polymeric Fibers Having Tissue Reactive Members
02/02/2012US20120027808 Nicotine immunonanotherapeutics
02/02/2012US20120027805 Controlled-Released Peptide Formulations
02/02/2012US20120027801 Polypeptides from neisseria meningitidis
02/02/2012US20120027792 Expression vectors able to elicit improved immune response and methods of using same
02/02/2012US20120027791 Antisense compound for inducing immunological tolerance
02/02/2012US20120027790 Immunological herpes simplex virus antigens and methods for use thereof
02/02/2012US20120027785 Chimera comprising bacterial cytotoxin and methods of using the same
02/02/2012US20120027784 Monomethylvaline compounds capable of conjugation to ligands
02/02/2012US20120027783 Monomethylvaline compounds capable of conjugation to ligands
02/02/2012US20120027778 Frizzled-Binding Agents and Uses Thereof
02/02/2012US20120027776 Diabetic model
02/02/2012US20120027770 Novel cell and therapeutical and diagnostical methods based thereon
02/02/2012US20120027766 Methods and means for treatment of osteoarthritis
02/02/2012US20120027764 Novel polypeptide, cdna encoding the same, and use thereof
02/02/2012US20120027759 Methods of enhancing t cell responsiveness
02/02/2012US20120027755 Prevention and treatment of alzheimer's disease
02/02/2012US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
02/02/2012US20120027746 Method for generating thrombin
02/02/2012US20120027745 Alanine-glyoxylate aminotransferase therapeutics
02/02/2012US20120027744 Modified heparinase iii and methods of sequencing therewith
02/02/2012US20120027743 Method for the Treatment of Hemophilia
02/02/2012US20120027742 Methods for treating adult respiratory distress syndrome
02/02/2012US20120027740 Method and means for producing tissues and tissues obtained
02/02/2012US20120027735 Symbiotic maple product compositions and methods
02/02/2012US20120027732 Thermoreversible collagen
02/02/2012US20120027726 Methods for Distributing High Levels of Therapeutic Agent Throughout the Cortex to Treat Neurological Disorders
02/02/2012US20120027723 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
02/02/2012US20120027722 Hepatitis c virus combination therapy
02/02/2012US20120027721 HCV Inhibitor and Therapeutic Agent Combinations
02/02/2012US20120027720 Peptide conjugates
02/02/2012US20120027706 Methods for treating skin pigmentation
02/02/2012US20120027705 Administration of cells and cellular extracts for rejuvenation
02/02/2012US20120027703 Novel proteasome-activating anti-aging peptides and compositions containing same
02/02/2012US20120027694 Inducible release vehicles
02/02/2012US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method
02/02/2012US20120027687 Fatty acid protein kinase c activators and anticoagulant for the treatment of stroke
02/02/2012US20120027684 Cancer therapy based on tumor associated antigens derived from cyclin d1
02/02/2012US20120027683 Diabetes t cell receptors